Clinical Trial: Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

Brief Summary: The purpose of this study is to collect samples for the purpose of developing a prenatal aneuploid test using circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant women who have a high-risk pregnancy undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS) and/or genetic amniocentesis. The results of the ccff aneuploid test will be compared to the chromosomal analysis obtained via CVS or amniocentesis.

Detailed Summary:
Sponsor: Sequenom, Inc.

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Sequenom, Inc.

Dates:
Date Received: September 1, 2009
Date Started: August 2009
Date Completion:
Last Updated: February 15, 2012
Last Verified: February 2012